Molecule profile · Module 9
Epitalon — evidence and research limits
MOLECULE PROFILE
- Evidence summary
- Preclinical evidence
- Khavinson and colleagues reported telomerase activation and telomere elongation in cultured human somatic cells. This is preclinical evidence, not a trial demonstrating longer human survival. Epitalon and epithalamin are distinct interventions; evidence for one must not be assigned to the other. The interpretation is specific to the studied molecule, formulation, route, population, and endpoint. Reported commercial regimens are not validated by a study of a different product or outcome.
- Regulatory status varies by jurisdiction
- The academic source does not establish a current authorization for every preparation sold under this name. Product identity, formulation, indication, jurisdiction, and current official labeling must be checked separately. A discussion of compounding or an advisory meeting is not a product approval.
Educational information for healthcare professionals and the general public. Not individual medical advice, diagnosis, treatment, or a recommendation to use a compound.
Identity and mechanism
The research discussed for Epitalon concerns telomerase activity and telomere length in cultured human somatic cells. Human origin of the cells does not turn a culture experiment into a human treatment trial. Epitalon and epithalamin are different interventions and should not share efficacy or safety claims without direct evidence.
Sequence: Epitalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG), as recorded in PubChem (CID 219042). The third residue is aspartic acid (Asp), not asparagine (Asn); a handbook that names asparagine describes a different sequence and should not be used to identify the material.
What the evidence supports
Khavinson and colleagues reported telomerase activation and telomere elongation in cultured human somatic cells. This is preclinical evidence, not a trial demonstrating longer human survival. Epitalon and epithalamin are distinct interventions; evidence for one must not be assigned to the other.
The interpretation is specific to the studied molecule, formulation, route, population, and endpoint. Reported commercial regimens are not validated by a study of a different product or outcome.
Regulatory context
The academic source does not establish a current authorization for every preparation sold under this name. Product identity, formulation, indication, jurisdiction, and current official labeling must be checked separately. A discussion of compounding or an advisory meeting is not a product approval.
Safety and uncertainty
Telomerase activity in culture does not determine long-term human safety. Do not conflate evidence for epithalamin with evidence for Epitalon when discussing safety or survival. Human safety cannot be inferred from a cell result, a product name, or lack of events in a small report. These educational adaptations do not provide an administration protocol.
Continue learning
Explore Module 9 in PEPTIDE Academy for the full evidence discussion.
References
Bibliographic sources shown for transparency. Citation verification pending; no citation is marked verified.
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-2. DOI: 10.1023/a:1025493705728. PMID: 12937682.DOI 10.1023/a:1025493705728 · PMID 12937682
- PubChem Compound Summary CID 219042, Epitalon (Ala-Glu-Asp-Gly). National Center for Biotechnology Information. Checked 19 October 2026.
Related resources
Molecule profile · Module 9
MOTS-c
MOTS-c is discussed as a mitochondrial-derived peptide involved in experimental metabolic signaling. The course separates its proposed biological origin from claims that an administered formulation reaches a particular compartment or reproduces normal exposure. Metabolic mechanisms provide research questions; they are not a demonstrated clinical indication.
Molecule profile · Module 3
AOD-9604
AOD-9604 is a modified fragment related to the C-terminal region of growth hormone. The rationale discussed in the course concerns metabolic effects attributed to the fragment, rather than assuming that it reproduces every action of full-length growth hormone. Identity, formulation, and route must be specified when comparing reports.
Molecule profile · Module 6
BPC-157
BPC-157 has been investigated in experimental tissue-repair models. The course examines tendon-cell survival, migration, and growth from explants as mechanistic findings. Those endpoints can help formulate hypotheses about repair; they do not directly measure recovery from a human tendon injury or return to sport.